Skip to main content
Caplight Logo









Gel4Med

Gel4Med

Private
MassachusettsHealthcare & Life Scienceshttps://www.gelformed.com/

Last Round

Grant

Jul 14, 2025

Total Funding Raised

$2.45M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Gel4Med is a biotechnology company that develops bio-inspired medical solutions for wound care and surgical reconstruction.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Advanced Materials, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales, Government Contracts

AI Layer

Non-AI

Keywords

regenerative medicineadvanced wound caresynthetic biomaterialspeptide hydrogeltissue engineeringsynthetic skin substituteself-assembling peptidessurgical wound matrixextracellular matrix mimicantibacterial biomaterialsmedical devicehydrogel dressingpeptide engineeringFDA 510(k) clearance

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Gel4Med Comparables

Compare Gel4Med with similar companies based on industry and business-model similarity.

Gel4Med comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Imbed Biosciences
89%
GelSana Therapeutics
86%
SweetBio
84%

Gel4Med Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJul 14, 2025
GrantMay 16, 2025
GrantMay 1, 2024
GrantOct 5, 2023
GrantSep 3, 2019
Seed
Apr 13, 2017

Key People

Founding team and executive leadership

Manav Mehta

Chief Executive Officer

Executive Team

Gel4Med Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Monthly visitors increased 117% MoM.

  • Jan 20, 2026

    Monthly visitors grew 526% MoM.

Gel4Med Filings

Explore SEC and related filing metadata, where available.

Gel4Med filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Gel4Med's valuation, stock price, and market status.

Is Gel4Med a public or private company?

Gel4Med is a private company.

What is the current stock price of Gel4Med?

Gel4Med is a private company with no public stock price. No recent secondary market data is available.

How much is Gel4Med worth (valuation)?

Valuation information for Gel4Med is not publicly available.

Can I buy Gel4Med stock?

Gel4Med shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Gel4Med's last funding round?

Gel4Med's most recent funding round was Grant on July 14, 2025.

Who are the main investors in Gel4Med?

Key investors in Gel4Med include NIH RADx, MassVentures, Massachusetts Life Sciences Center, Breakout Ventures, U.S. Department of War.

Will Gel4Med IPO soon?

No public IPO plans have been announced for Gel4Med.

How can I track Gel4Med secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Gel4Med's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMassachusetts
Employee Range17
Year Founded2015
Last FundingJul 14, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?